Potential Antitumor Effects of Pomegranates and Its Ingredients.

about

Potential Antitumor Effects of Pomegranates and Its Ingredients.

Item

http://www.wikidata.org/entity/Q42136651

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Potential Antitumor Effects of Pomegranates and Its Ingredients.

@en

Potential Antitumor Effects of Pomegranates and Its Ingredients.

@nl

type

Item

label

Potential Antitumor Effects of Pomegranates and Its Ingredients.

@en

Potential Antitumor Effects of Pomegranates and Its Ingredients.

@nl

prefLabel

Potential Antitumor Effects of Pomegranates and Its Ingredients.

@en

Potential Antitumor Effects of Pomegranates and Its Ingredients.

@nl

P1476

Potential Antitumor Effects of Pomegranates and Its Ingredients.

@en

P2093

Arshad H Rahmani

http://www.w3.org/2001/XMLSchema#string

Mohammed A Alsahli

http://www.w3.org/2001/XMLSchema#string

Saleh A Almatroodi

http://www.w3.org/2001/XMLSchema#string

P2860

Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy

Bioavailability of curcumin: problems and promises

NF-kappaB in cancer: from innocent bystander to major culprit

Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice.

Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis.

Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways.

Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer

Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation.

Oral sequelae of head and neck radiotherapy.

Pomegranate sensitizes Tamoxifen action in ER-α positive breast cancer cells

P304

136-140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/PHREV.PHREV_25_17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28989248

http://www.w3.org/2001/XMLSchema#string

P932

5628519

http://www.w3.org/2001/XMLSchema#string